Drug profile · INN
idelalisib
ZYDELIG
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
idelalisib (ZYDELIG) is an FDA-listed pharmaceutical active ingredient. Associated with Gilead Sciences Pty Limited. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN idelalisib
Brand ZYDELIG
Route ORAL
Formulation TABLET
ATC code L01XX47
Originator Gilead Sciences Pty Limited
Frequently asked questions
What is idelalisib?
idelalisib (ZYDELIG) is an FDA-listed pharmaceutical active ingredient. Associated with Gilead Sciences Pty Limited. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for idelalisib?
ZYDELIG is a marketed brand name for idelalisib. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of idelalisib?
idelalisib has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.